The Role of Preexisting Pathology in the Development of Neointimal Hyperplasia in Coronary Artery Bypass Grafts

Journal of Surgical Research

Volumn 142, Issue 2, 2007, Pages 351-356

  Kon, Zachary N ^a   White, Charles ^a   Kwon, Michael H ^a   Judy, Jean ^a   Brown, Emile N ^a   Gu, Junyan ^a   Burris, Nicholas S ^a   Laird, Patrick C ^a   Brown, Talitha ^a   Brazio, Phillip S ^a   Gammie, James ^a   Brown, James ^a   Griffith, Bartley P ^a   Poston, Robert S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

computed tomographic angiography; coronary artery bypass; endothelium; matrix metalloproteinase; neointimal hyperplasia

Indexed keywords

GELATINASE A;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; INTIMA; MALE; PRIORITY JOURNAL; RISK FACTOR; SAPHENOUS VEIN GRAFT; TUNICA MEDIA;

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SAPHENOUS VEIN; TUNICA INTIMA;

EID: 34548683475     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.062     Document Type: Article

References (21)

1. Fitzgibbon G.M., Kafka H.P., Leach A.J., et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616
2. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916
3. Reardon M.J., Conklin L.D., Reardon P.R., et al. Coronary artery bypass conduits: Review of current status. J Cardiovasc Sur 97 (1997) 916
4. Zwolak R.M., Adams M.C., and Clowes A.W. Kinetics of vein graft hyperplasia: Association with tangential stress. J Vasc Surg 5 (1987) 126
5. Thiene G., Miazzi P., Valsecchi M., et al. Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. Thorax 35 (1980) 519
6. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90 (2002) 251
7. Uzui H., Lee J.D., Shimizu H., et al. The role of proteintyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149 (2000) 51
8. Morishita R., Gibbons G.H., Horiuchi M., et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci 92 (1995) 5855
9. Mann M.J., Gibbons G.H., Kernoff R.S., et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci 92 (1995) 4502
10. Ehsan A., Mann M.J., Dell'Acqua G., et al. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Sur 121 (2001) 714
11. PREVENT IV Investigators. Efficacy and safety of Edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: A Randomized Controlled Trial. JAMA 294 (2005) 2446
12. Martuscelli E., Romagnoli A., D'Eliseo A., et al. Evaluation of venous and arterial conduit patency by 16-slice spiral computed tomography. Circulation 110 (2004) 3234
13. Burris N., Schwartz K., Tang C.-M., et al. Catheter-based infrared light scanner as a tool to assess conduit quality in coronary artery bypass surgery. J Thorac Cardiovasc Surg 133 (2007) 419
14. Patterson M.A., Leville C.D., Hower C.D., et al. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture. J Surg Res 95 (2001) 67
15. Lesser J.R., Flygenring B., Knickelbine T., et al. Clinical utility of coronary CT angiography: Coronary stenosis detection and prognosis in ambulatory patients. Catheter Cardiovasc Interv 69 (2006) 64
16. Marano R., Storto M.L., Maddestra N., et al. Noninvasive assessment of coronary artery bypass graft with retrospectively ECG-gated four-row multi-detector spiral computed tomography. Eur Radiol 14 (2004) 1353
17. von Offenberg S.N., Cummins P.M., Birney Y.A., et al. Cyclic strain-induced endothelial MMP-2: Role in vascular smooth muscle cell migration. Biochem Biophys Res Commun 320 (2004) 325
18. Blankenhorn D.H., Nessim S.A., Johnson R.L., et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257 (1987) 3233
19. Cashin-Hemphill L., Mack W.J., Pogoda J.M., et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis: A 4-year follow-up. JAMA 264 (1990) 3013
20. The post-coronary artery bypass graft trial investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 153
21. Lau G.T., Ridley L.J., Bannon P.G., et al. Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. Circulation 114 (2006) 435